PharmEasy parent API Holdings withdraws Rs 6,250 cr DRHP, eyes rights issue

API Holdings has pulled its 2021-filed Rs 6,250 crore IPO papers from SEBI and is weighing a rights issue to existing backers including Prosus, TPG and Temasek. The retreat reflects cooling appetite for new-age listings and follows the Rs 4,546 crore Thyrocare buy that stretched the balance sheet.

— Filed Wed, 27 May, 2026, 03:16 IST · Source Moneycontrol · News Web · Updated

API Holdings, parent of online pharmacy PharmEasy, has withdrawn its Rs 6,250 crore DRHP filed with SEBI in 2021 and is weighing a rights issue to existing shareholders to raise capital amid weak market conditions for new-age listings.

Why this matters

PharmEasy parent's IPO retreat marks a major reset after the debt-funded Rs 4,546 cr Thyrocare buyout, shifting funding strategy from public markets to existing PE/sovereign backers.

Retail-company signals steady at 1,224 in last 90 days, reflecting consistent corporate activity.

Also reported by